A Glimpse Into The Expert Outlook On Accolade Through 7 Analysts

Loading...
Loading...

Analysts' ratings for Accolade ACCD over the last quarter vary from bullish to bearish, as provided by 7 analysts.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 3 3 1 0 0
Last 30D 1 0 0 0 0
1M Ago 2 2 1 0 0
2M Ago 0 1 0 0 0
3M Ago 0 0 0 0 0

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $14.71, a high estimate of $17.00, and a low estimate of $12.00. Marking an increase of 8.96%, the current average surpasses the previous average price target of $13.50.

Breaking Down Analyst Ratings: A Detailed Examination

In examining recent analyst actions, we gain insights into how financial experts perceive Accolade. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Ryan MacDonald Needham Maintains Buy $17.00 -
Jailendra Singh Truist Securities Raises Buy $16.00 $15.00
Jessica Tassan Piper Sandler Raises Overweight $15.00 $12.00
Stan Berenshteyn Wells Fargo Raises Equal-Weight $12.00 $10.00
John Ransom Raymond James Raises Outperform $16.00 $12.00
David Grossman Stifel Lowers Buy $15.00 $17.00
Jessica Tassan Piper Sandler Lowers Overweight $12.00 $15.00

Key Insights:

Loading...
Loading...
  • Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Accolade. This insight gives a snapshot of analysts' perspectives on the current state of the company.
  • Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Accolade compared to the broader market.
  • Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Accolade's stock. This comparison reveals trends in analysts' expectations over time.

To gain a panoramic view of Accolade's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.

Stay up to date on Accolade analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

All You Need to Know About Accolade

Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. It generates revenue by providing personalized health guidance solutions to members.

Accolade: Delving into Financials

Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.

Positive Revenue Trend: Examining Accolade's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 9.26% as of 30 November, 2023, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.

Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -21.2%, the company may need to address challenges in effective cost control.

Return on Equity (ROE): Accolade's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -4.83%, the company may encounter challenges in delivering satisfactory returns for shareholders.

Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -2.57%, the company may need to address challenges in generating satisfactory returns from its assets.

Debt Management: Accolade's debt-to-equity ratio is below the industry average at 0.56, reflecting a lower dependency on debt financing and a more conservative financial approach.

The Core of Analyst Ratings: What Every Investor Should Know

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...